Suppr超能文献

Use of biologics in inflammatory bowel disease patients with cirrhosis.

作者信息

Dhere Tanvi

出版信息

Inflamm Bowel Dis. 2011 Feb;17(2):E15-6. doi: 10.1002/ibd.21434.

Abstract
摘要

相似文献

1
Use of biologics in inflammatory bowel disease patients with cirrhosis.
Inflamm Bowel Dis. 2011 Feb;17(2):E15-6. doi: 10.1002/ibd.21434.
2
[Anti-TNF agents in inflammatory bowel disease: indications and management].
Gastroenterol Clin Biol. 2004 May;28(5 Suppl):D61-9. doi: 10.1016/s0399-8320(04)94989-5.
4
[Biologics in current therapy for inflammatory bowel disease].
Nihon Rinsho Meneki Gakkai Kaishi. 2009 Jun;32(3):168-79. doi: 10.2177/jsci.32.168.
5
The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
Expert Rev Gastroenterol Hepatol. 2015;9 Suppl 1:27-34. doi: 10.1586/17474124.2015.1091307.
6
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Gastrointest Endosc Clin N Am. 2019 Jul;29(3):405-419. doi: 10.1016/j.giec.2019.03.001. Epub 2019 Apr 12.
8
[New inflammatory bowel disease drugs targeting the inflammatory cascade].
Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B72-8.
9
Therapeutic potential of infliximab in inflammatory bowel disease.
Gastroenterol Nurs. 1999 Sep-Oct;22(5):199-208. doi: 10.1097/00001610-199909000-00003.

引用本文的文献

1
Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study.
Therap Adv Gastroenterol. 2021 Oct 22;14:17562848211037094. doi: 10.1177/17562848211037094. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验